Minerva Neurosciences | Des Atouts

Prix De L'Action
6.33
Variation Quotidienne
0.02 0.32%
Mensuellement
46.53%
Annuel
222.96%
Q1 Prévisions
2.46




Des Atouts Changement Date
Acadia Pharmaceuticals USD 1.33B 105.22M 2025-09
Adma Biologics USD 568.69M 10.31M 2025-09
ALKERMES USD 2.33B 76.7M 2025-09
Alterity Therapeutics Limited AUD 27.32M 6.07M 2023-06
AstraZeneca USD 114.07B 382M 2025-12
BioCryst Pharmaceuticals USD 446.42M 10.76M 2025-09
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Cipla INR 401.64B 27.77B 2025-09
Clal Biotechnology ILS 158.39M 24.3M 2023-12
Compugen USD 97.84M 8.68M 2025-09
CSL USD 39.4B 957M 2025-06
Dynavax Technologies USD 946.51M 28.06M 2025-09
Eli Lilly USD 114.94B 14.01B 2025-09
Esperion Therapeutics USD 364.02M 16.93M 2025-09
GlaxoSmithKline GBP 61.12B 221M 2025-12
Grifols EUR 23.29B 3.35M 2025-09
Halozyme Therapeutics USD 2.22B 167.33M 2025-09
Ionis Pharmaceuticals USD 3.03B 47.96M 2025-09
J&J USD 199.21B 6.39B 2025-12
Merck USD 129.55B 12.02B 2025-09
Minerva Neurosciences USD 28.09M 2.33M 2025-09
Neurocrine Biosciences USD 4.63B 365.8M 2025-12
Novartis USD 107.29B 2.89B 2025-09
Novavax USD 1.18B 156.66M 2025-09
Pfizer USD 208.73B 2.64B 2025-09
Roche Holding CHF 100.7B 5.94B 2025-12
Sanofi EUR 126.81B 2.99B 2025-12
Takeda JPY 15.41T 938.47B 2025-12
Vanda Pharmaceuticals USD 601.14M 23.61M 2025-09


Minerva Neurosciences Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.